纵横研报
Archive · Page 02 / 35

更早研报

第 2 页 · 按发布时间倒序聚合。

1021Reports · 942Tickers · 196Industries
·AI 半导体设备 ·内部研究

Hwatsing Technology: A Real CMP Champion, Priced as if the Platform Story Is Already Won

Hwatsing Technology (688120.SHG) is China's domestic leader in chemical-mechanical-polishing equipment, expanding from a single CMP tool into a broader semiconductor-equipment and services platform. 2025 revenue grew 36.5% to CNY 4.65 billion and net profit rose to CNY 1.08 billion, but operating cash flow fell 30.7% as inventory and receivables absorbed cash, even as the stock trades near 120.6x trailing earnings around the 99th percentile of its own valuation history. Rating Avoid: the CMP franchise and platform ambition are real, but the price already assumes a platform future the segment disclosures cannot yet prove, with the ideal buy zone at CNY 110 to 125.

688120.SHG Hwatsing Technology Co., Ltd. #Semiconductor Equipment#CMP#China Substitution#Valuation Premium#Platform Transition#Cash Conversion
Avoid
·电力设备 ·内部研究

Pinggao Electric: The Cleanest UHV Switchgear Play, But Orders Are Not Yet Revenue

Pinggao Electric is a state-backed specialist in high-voltage and ultra-high-voltage (UHV) switchgear, with 2025 revenue of CNY 12.52 billion and net profit of CNY 1.12 billion, riding State Grid's newly enlarged CNY 4 trillion 2026-2030 capex plan and fresh tender wins of about CNY 12.23 billion in March 2026 and CNY 20.92 billion in June 2026. Rating Hold: revenue is recognized only at customer sign-off, not at tender announcement, and 2025 operating cash flow fell to CNY 0.81 billion from CNY 3.01 billion in 2024 even as profit rose, so the current CNY 17.69 price already pays a fair cycle multiple with the ideal buy zone at CNY 12.5 to 14.5.

600312.SHG Henan Pinggao Electric Co., Ltd. #UHV Grid Buildout#State Grid Tenders#Revenue Recognition Lag#Working Capital Cycle#Customer Concentration#Smart Factory Capex
Hold
OUST.US logo
·激光雷达(汽车电子·自动驾驶感知) ·内部研究

Ouster: A Much Better Lidar Company, Priced Like the Transition Is Already Won

Ouster is a digital-lidar and perception supplier that has broadened from a single-product sensor maker into an industrial-automation and smart-infrastructure platform, with 2025 revenue of $169.4 million (up from $83.3 million in 2023) and Q1 2026 revenue of $49 million, up 49% year over year, alongside a 43% GAAP gross margin. Rating Watch: the July 2, 2026 $200 million common-stock offering at $55.22 per share confirms management will dilute shareholders whenever the stock is rich, and at the July 3 close of $49.84 the market is already paying for sustained 30%-50% growth and a clean path to profitability, leaving the ideal buy zone at $20 to $22.

OUST.US Ouster, Inc. #Physical AI Narrative#Post-SPAC Recovery#Equity Dilution Risk#Industrial Lidar Niche#Chinese Lidar Competition#Perception Platform Expansion
Watch
·化工·香精香料 ·内部研究

DSM-Firmenich: A Genuine Portfolio Cleanup, Already Priced for the Improvement to Continue

DSM-Firmenich is a Swiss-domiciled flavors, fragrances and health-ingredients platform whose 2025 continuing-operations results (sales of EUR 9.03 billion, adjusted EBITDA of EUR 1.77 billion at a 19.6% margin) show a business getting cleaner as it exits Animal Nutrition & Health to CVC for about EUR 2.2 billion, while Perfumery & Beauty carries the group with 8% like-for-like growth in the first quarter of 2026 even as Taste, Texture & Health and Health, Nutrition & Care remain uneven. Rating Hold: the portfolio has genuinely improved faster than the market expected a year ago, but at EUR 85 the price already reflects a fair share of that cleanup, with the ideal buy zone at EUR 64 to 70.

DSFIR.AMS DSM-Firmenich AG #Merger Integration#Portfolio Simplification#Fine Fragrance#Synergy Delivery#Family Voting Control#Peer Valuation Gap
Hold
FRES.LSE logo
·白银矿业 ·内部研究

Fresnillo: A Genuine Re-Rating, But the Price Already Assumes the Hard Part Is Done

Fresnillo is the world's largest primary silver producer and one of Mexico's largest gold producers, whose 2025 results (adjusted revenue of US$4.65 billion, EBITDA of US$2.80 billion, and net cash of US$1.92 billion) were driven mainly by a favorable metals tape rather than a structural improvement, even as the company cut 2026 guidance to 42-46.5 million ounces of silver and 500-550 thousand ounces of gold after grade and mine-plan setbacks at Fresnillo, Saucito and Herradura. Rating Hold: high cash generation and scarce silver exposure are real, but at £29.22 the price already discounts favorable metals while execution risk, Mexico concentration and Peñoles' 74.99% control remain unresolved, with the ideal buy zone at £15 to £17.

FRES.LSE Fresnillo plc #Silver Mining#Precious Metals#Mexico Risk#Dividend Yield#Governance Discount#Reserve Life
Hold
·AI 半导体设备 ·内部研究

ACM Research Shanghai: A Genuine Platform Story, Priced for Zero Margin of Safety

ACM Research Shanghai is the Shanghai-listed operating core of a dual-listed Chinese semiconductor wet-process equipment group, whose U.S. parent ACM Research (ACMR.US) holds a 73.6% stake but trades at a steep discount to the A-share line's implied look-through value. 2025 revenue rose 20.8% to CNY 6.79 billion and net profit rose 21.1% to CNY 1.40 billion, but operating cash flow collapsed to just CNY 239 million from CNY 1.22 billion and turned negative in the first quarter of 2026, even as the stock trades near 130 times trailing earnings and about 180% above the parent-implied look-through value. Rating Watch: the platform story is real, but the price already assumes near-flawless execution while cash conversion has weakened, with the ideal buy zone at CNY 140 to 150.

688082.SHG ACM Research Shanghai, Inc. #Semiconductor Equipment#Dual Listing#China Substitution#Cash Conversion#Advanced Packaging#Valuation Premium
Watch
·油服与能源技术 ·内部研究

Saipem: The Offshore Repair Is Real, but the Subsea7 Merger Remains Unresolved

Saipem is an Italian offshore engineering, construction and drilling contractor whose earnings recovery is now driven mainly by its Asset Based Services offshore segment, with a pending merger with Subsea7 standing as the central event-driven value lever. 2025 revenue rose to 15.5 billion EUR and EBITDA grew 29.1% to 1.716 billion EUR while pre-IFRS 16 net cash climbed to 999 million EUR, yet reported backlog slipped from 34.1 billion EUR to 29.7 billion EUR and Australia's antitrust regulator pushed the Subsea7 deal into a Phase 2 review on 2026-07-03. Rating Hold: the offshore repair is real and the balance sheet is strong, but the current price already discounts much of that progress while merger-approval risk stays unresolved, with the ideal buy zone at 3.5 to 3.9 EUR.

SPM.MI Saipem S.p.A. #Offshore Engineering#Oilfield Services#Merger Arbitrage#Antitrust Review#Free Cash Flow#Energy Services
Hold
·汽车制造 ·内部研究

Stellantis: Deep Discount, Real Net Cash, and a Turnaround Still on Trial

Stellantis is a global multi-brand automaker (Jeep, Ram, Peugeot, Fiat and more) whose economics hinge on North America, entering 2026 after a 22.3 billion EUR net loss in the 2025 reset year. Industrial net cash of 9.5 billion EUR and Q1 2026's return to growth (revenue up 6%, adjusted operating margin 2.5%) buy the turnaround time, yet at 5.81 USD the shares sit between the ideal-buy zone and fair value while warranty scars and tariffs keep normalized earning power suspect. Rating Watch: deep discount and net cash create upside, but the turnaround still needs proof in North America, warranty costs, and cash generation.

STLA.US Stellantis N.V. #automotive#turnaround#North America#tariffs#FaSTLAne 2030#warranty provisions
Watch
SSRM.US logo
·黄金矿业 ·内部研究

SSR Mining: Cash-Rich After the Çöpler Exit, With the Real Test Still Ahead

SSR Mining is an Americas-focused gold-and-silver producer running four mines (Marigold, Cripple Creek & Victor, Seabee, Puna), guiding 450,000–535,000 gold-equivalent ounces for 2026 after completing its exit from Türkiye. The June 24, 2026 Çöpler sale converted the portfolio's biggest source of risk into about 1.49 billion USD of cash, implying at least roughly 1.82 billion USD pro forma, yet at 30.31 USD the stock already prices in much of the de-risking while the larger capital-allocation test is still ahead. Rating Hold: the balance sheet is far better after Çöpler, but the current price discounts much of that cleanup before redeployment is fully proven.

SSRM.US SSR Mining Inc. #gold mining#silver#Çöpler divestment#capital allocation#CC&V#event-driven
Hold
LEGN.US logo
·制药 ·内部研究

Legend Biotech: CARVYKTI Is a Real Franchise, Self-Funding Is Still Unproven

Legend Biotech is a commercial-stage cell-therapy company whose economics are dominated by CARVYKTI, the BCMA CAR-T it shares equally with Johnson & Johnson outside Greater China while bearing and retaining 70% in Greater China. Collaboration revenue reached 944.8 million USD in 2025 and quarterly CARVYKTI trade sales hit 597 million USD in Q1 2026, up 62% year over year, yet the same quarter still showed a 54.3 million USD net loss and June 2026 brought a follow-on offering of about 226 million USD gross. Rating Hold: CARVYKTI is a real franchise, but the current price does not pay generously for single-asset concentration, shared economics, and continuing dilution risk, and new capital only gets attractive at 22 to 24 USD.

LEGN.US Legend Biotech Corporation #CAR-T#Cell Therapy#CARVYKTI#Multiple Myeloma#Biotechnology#Licensing Partnerships
Hold
AG.US logo
·白银矿业 ·内部研究

First Majestic Silver: A Better Miner After Los Gatos, No Longer a Cheap One

First Majestic is a Mexico-focused silver-and-gold miner whose earnings engine was rebuilt by the January 2025 Gatos Silver acquisition, a deal that added a 70% stake in Los Gatos, lifted scale and cost quality, and left former Gatos holders with about 38% of the company. 2025 delivered record revenue of 1.257 billion USD and free cash flow of 470.6 million USD, and Q1 2026 added 476.7 million USD of revenue with 223.5 million USD of free cash flow, yet 2026 guidance calls for lower silver output, Q1 AISC ran 29.76 USD per ounce, and the Mexican tax dispute remains unresolved. Rating Hold: Los Gatos made First Majestic a better miner, but at 17.82 USD the price already reflects much of that upgrade, and the entry only gets attractive below 16 USD.

AG.US First Majestic Silver Corp. #Silver#Gold#Precious Metals Mining#Los Gatos#Mexico#High Beta
Hold
300759.SHE logo
·医药研发外包 ·内部研究

Pharmaron Beijing: Order Momentum Returns, but the Platform Is Still Unfinished

Pharmaron Beijing is an integrated drug R&D outsourcing platform whose laboratory-services engine, RMB 8.16 billion of FY2025 revenue at a 45.1% gross margin, still funds the build-out of CMC, clinical and biologics capacity. FY2025 revenue grew 14.8% to RMB 14.10 billion while attributable profit fell 7.2% to RMB 1.66 billion on a prior-year investment-gain base, and Q1 2026 new orders grew more than 30% with CMC orders up over 50%, yet North America supplies roughly 61.8% of revenue under a sector-wide geopolitical discount. Rating Hold: a good discovery-and-chemistry franchise is funding a real but unfinished move into broader CRDMO, leaving the current CNY 29.11 price short of a margin-of-safety entry below CNY 25.

300759.SHE Pharmaron Beijing Co., Ltd. 康龙化成 #CRO#CDMO#China CXO#Pharmaceutical Outsourcing#BIOSECURE#Order Recovery
Hold
NNE.US logo
·核能 ·内部研究

NANO Nuclear Energy: A Well-Capitalized Microreactor Option, Priced Ahead of Commercial Proof

NANO Nuclear is a pre-revenue microreactor developer, best read as a listed basket of nuclear options funded by an unusually large cash balance, with its KRONOS reactor now the lead asset in formal NRC review. Total liquidity of 568.7 million USD at March 2026 removes near-term financing stress, but there is still no product revenue and commercialization is only an early-2030s aspiration. Rating Hold: the cash pile makes permanent loss less likely, yet at 20.75 USD the price already pays for years of regulatory progress that has not yet happened.

NNE.US NANO Nuclear Energy Inc. #Microreactors#Advanced Nuclear#KRONOS#AI Power Demand#Pre-revenue Optionality
Hold
CDE.US logo
·黄金矿业 ·内部研究

Coeur Mining: A Stronger Seven-Mine Platform, No Longer Cheap Enough to Ignore the Cycle

Coeur Mining is a North American precious-metals producer whose earnings now come from seven mines spanning gold, silver and, after the March 2026 New Gold deal, copper. Q1 2026 brought record adjusted EBITDA of 474.9 million USD and 340.8 million USD of operating cash flow, ending the quarter in a net-cash position, but 2026 guidance rests on aggressive metal-price assumptions of 4,550 USD per ounce gold and 77.50 USD per ounce silver. Rating Hold: the platform is far stronger than before Rochester, SilverCrest and New Gold, yet at 16.54 USD the price already assumes high metals and smooth integration, leaving no margin of safety against normalization.

CDE.US Coeur Mining, Inc. #Silver#Gold#Copper#Precious Metals Mining#New Gold Acquisition#Commodity Cyclical
Hold
BIO.US logo
·生命科学工具 ·内部研究

Bio-Rad Laboratories: A Company in Transition, Priced Without a Margin of Safety

Bio-Rad is a diversified life-science tools and clinical-diagnostics supplier whose core operations generated 2.58 billion USD of 2025 sales, complicated by an unusually large Sartorius AG stake that dominates its GAAP earnings. Q1 2026 brought a 527.1 million USD net loss driven by a 727.7 million USD fair-value drop on the Sartorius stake, even as the operating business still produced 108.1 million USD of operating cash flow, and management cut full-year currency-neutral revenue guidance to a range of -3.0% to +0.5%. Rating Hold: durable niche assets and real asset backing, but at 297.09 USD the price already assumes the 2026 slowdown is manageable and leaves no margin of safety.

BIO.US Bio-Rad Laboratories, Inc. #Life Science Tools#Clinical Diagnostics#ddPCR#Sartorius Stake#Sum-of-the-Parts#Turnaround
Hold
·水产养殖 ·内部研究

Mowi ASA: A License-Constrained Salmon Platform at a Fair, Not Forgiving, Price

Mowi is the world's largest and most geographically diversified Atlantic salmon farmer, controlling the full chain from feed and genetics through farming, processing and branded sales across more than 70 countries. Q1 2026 revenue hit a record EUR 1.544 billion even as operational EBIT per kg fell to EUR 1.62 from EUR 1.98 a year earlier, and the June 2026 sale of the loss-making Canada East unit to Cooke for CAD 225 million signals a pivot from chasing tonnes toward cleaner regional returns. Rating Hold: scale and integration are real advantages, but at roughly 16.8x underlying EPS the stock offers too little margin of safety against biology, Norwegian tax risk and weak-region drag.

MOWI.OL Mowi ASA #Aquaculture#Atlantic Salmon#Norway#Vertical Integration#Dividend#Commodity Cyclical
Hold
GH.US logo
·诊断检测 ·内部研究

Guardant Health: A Rerating Built on a Company in Transition

Guardant Health is a blood-based oncology diagnostics company whose economic center still sits in advanced-cancer therapy selection while its upside narrative has shifted toward Shield, a colorectal-cancer screening test that just won UnitedHealth coverage for 100 million lives. 2025 revenue reached 982 million USD, up 33% year on year, with non-GAAP gross margin improving from 62% to 66%, yet the company still posts negative owner earnings and trades near 17x forward EV/sales, above larger and cash-generative peer Natera. Rating Watch: an excellent liquid-biopsy franchise, but the stock already prices in broad Shield adoption and a faster profit path than has been proven, with the ideal buy zone at 68 to 74 dollars.

GH.US Guardant Health, Inc. #liquid biopsy#oncology diagnostics#Shield screening#companion diagnostics#Natera#colorectal cancer screening#valuation
Watch
·油服与能源技术 ·内部研究

Aker Solutions: A Leaner Contractor Priced Without a Margin of Safety

Aker Solutions is a Norwegian offshore-energy contractor that has become measurably leaner since folding its subsea business into the OneSubsea joint venture in 2023, with earnings driven mainly by offshore oil-and-gas project execution and life-cycle services rather than renewables engineering. FY2025 revenue reached NOK 63.2bn with EBITDA excluding special items of NOK 5.284bn (8.4% margin), but management already guides 2026 revenue down to around NOK 50bn as the Norwegian offshore capex cycle rolls over from its 2025 peak, while renewables and transition work made up only 20% of FY2025 revenue and fell to just 4% of Q1 2026 order intake. Rating Hold: at NOK 44.50 the stock trades inside its acceptable-hold range against a conservative owner-earnings fair value of NOK 26-32, leaving no real margin of safety for a genuinely improved but still cyclical business.

AKSO.OL Aker Solutions ASA #Offshore Energy Services#Norwegian Oil & Gas#OneSubsea#Life Cycle Services#Energy Transition#Norwegian Continental Shelf
Hold
601012.SHG logo
·光伏制造 ·内部研究

LONGi Green Energy: A Real Transition, Not Yet a Real Turnaround

LONGi Green Energy is a former monocrystalline-wafer champion pivoting its integrated solar manufacturing business toward back-contact (BC) modules and, since a January 2026 acquisition, early-stage energy storage. In 2025 revenue fell 14.8% to CNY 70.35bn with a CNY 6.42bn attributable net loss, wafers ran a negative 5.30% gross margin, and only the power-station segment stayed solidly profitable, even as BC module shipments reached 22.87GW and rose to 8.34GW of the 12.62GW shipped in the first quarter of 2026. Rating Hold: the balance sheet still holds CNY 53.35bn of cash against CNY 35.20bn of debt, but at CNY 13.12 the stock already prices in a successful transition that the financials have not yet delivered.

601012.SHG LONGi Green Energy Technology Co., Ltd. #Solar Manufacturing#BC Modules#Silicon Wafers#Industry Overcapacity#Energy Storage#A-Share Solar
Hold
·工业自动化 ·内部研究

Estun Automation: A Good Company at a Bad A-Share Price

Estun Automation is a Chinese full-stack industrial-automation group whose robot and intelligent-manufacturing-systems business now supplies 81.8% of 2025 revenue and grew 31.8% year on year, even as the legacy automation-components segment shrank 8.7%. Gross margin has only partly recovered to 29.5%, the top five customers took 37.2% of nine-month 2025 revenue, and the Shenzhen line trades above a 250x trailing P/E, roughly 2.5 times richer than the newly listed Hong Kong shares on a per-share basis. Rating Watch: domestic share gains and a stronger post-listing balance sheet are real, but the A-share price already discounts a cleaner margin and cash-conversion story than the filings currently support.

002747.SHE Estun Automation Co., Ltd. #Industrial Robotics#Motion Control#A+H Listing#Valuation Premium#Margin Recovery#China Automation
Watch
·AI 半导体设备 ·内部研究

KINGSEMI: A Scarce Domestic Track Asset, Priced Well Ahead of the Evidence

KINGSEMI is a specialized Chinese semiconductor-equipment maker in front-end coat/develop tracks and single-wafer wet tools, now controlled by NAURA. 2025 revenue grew 11% to CNY 1.95 billion, but attributable profit fell 65% to CNY 71.7 million, and a one-month 79% surge lifted the market cap to CNY 88.5 billion, about 45 times sales. Rating Avoid: a genuinely scarce front-end track franchise, but at CNY 439 the price already assumes a mature cleaning-and-platform business the operating evidence does not yet support.

688037.SHG KINGSEMI Co., Ltd. #Semiconductor equipment#Front-end coat/develop#Wafer cleaning#Domestic substitution#NAURA control change#Valuation risk
Avoid
6503.TSE logo
·电气设备 ·内部研究

Mitsubishi Electric: A Conglomerate in Transition, Fully Priced

Mitsubishi Electric is a diversified Japanese electrical group earning from factory automation, infrastructure, HVAC and building systems, semiconductors and defense, with FY2026 revenue of ¥5.9 trillion. All five segments grew profit in FY2026 and management is pushing ROIC-based reform, ¥280 billion of cross-shareholding sales and a richer service mix, yet free cash flow of ¥231.5 billion still trails net profit of ¥407.7 billion while the stock has rerated to around 30x trailing earnings. Rating Hold: business quality and capital discipline are genuinely better, but at ¥5,858 the price already discounts much of the reform before cash conversion catches up, leaving little margin of safety.

6503.TSE Mitsubishi Electric Corporation #Factory automation#Infrastructure and defense#Power semiconductors#Capital allocation reform#Rerating#Japanese industrials
Hold
3690.HK logo
·互联网平台 ·内部研究

Meituan: A High-Quality Franchise With Temporarily Broken Earnings

Meituan is China's largest local-services platform, monetizing food delivery, in-store and hotel services, and instant retail, with 2025 revenue of RMB364.9 billion. A subsidy war with Alibaba and JD flipped Core Local Commerce from RMB52.4 billion of 2024 operating profit into a loss and pushed the group to a RMB23.4 billion net loss in 2025, even as platform GTV and transaction volume kept growing. Rating Hold: the franchise stays high-quality and the balance sheet strong, but at HK$68.50 the shares lack a clear margin-of-safety cushion until Core Local Commerce proves post-war profitability can stick.

3690.HK Meituan #Local services#Food delivery#Instant retail#Subsidy war#Platform economics
Hold
·电子材料 ·内部研究

Anji Microelectronics: A High-Quality Compounder, but a Better Company Than Stock

Anji Microelectronics is China's leading CMP-slurry maker, supplying semiconductor polishing slurries and a widening platform of formulated wet electronic chemicals, with 2025 revenue of CNY 2.50bn (up 36%) and a disclosed global CMP-slurry share that climbed from about 7% in 2022 to 13% in 2025. The usage story is genuine: attributable net profit grew 47% to CNY 784m and functional wet chemicals surged 64%, yet after a roughly 161% one-year run the stock trades near CNY 305, about 88 times 2025 earnings, a price that already capitalizes years of flawless execution. Rating Watch: a real hard-tech compounder, but currently a better company than stock, with a serious re-underwriting zone only back at CNY 190-230.

688019.SHG Anji Microelectronics Technology (Shanghai) Co., Ltd. #CMP slurry#semiconductor materials#domestic substitution#wet chemicals#valuation#SUN-R
Watch
SHA.XETRA logo
·汽车零部件 ·内部研究

Schaeffler: More Interesting Than Its Multiple, but Not Yet Safer Than It Implies

Schaeffler is a German motion-technology supplier (bearings, automotive aftermarket, and electrification systems), reshaped into a four-division group after the 2024 Vitesco merger, with 2025 revenue of EUR 23.5 billion. The legacy bearings and aftermarket businesses are better than the stock's distressed-supplier multiple implies, but E-Mobility still ran a -16% adjusted EBIT margin in 2025 and EUR 4.9 billion of net debt keeps the group below investment grade, so the cheap multiple reflects real transition risk rather than hidden value. Rating Watch: buy only at a larger discount (ideal entry EUR 6.2-6.9) or after clearer proof that E-Mobility losses and leverage are turning.

SHA.XETRA Schaeffler AG #auto components#Vitesco merger#E-Mobility#bearings#turnaround#valuation
Watch